End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.38 CNY | 0.00% | -0.87% | -51.60% |
06-26 | Walvax Biotechnology Ends Vaccine Development Deal With Abogen Biotechnology | MT |
06-18 | Walvax Terminates Coronavirus Vaccine Trials Due to Mutations | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.60% | 2.5B | |
+2.99% | 94.76B | |
-4.34% | 37.58B | |
-10.41% | 33.3B | |
+75.79% | 27.92B | |
-14.61% | 15.85B | |
-3.46% | 13.79B | |
-12.31% | 11.51B | |
+184.77% | 10.9B | |
-54.13% | 9.27B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Walvax Biotechnology Ends Vaccine Development Deal With Abogen Biotechnology